The U.S. Food and Drug Administration and the Federal Trade Commission are alerting the public to be wary of Internet sites and other promotions for products that claim to diagnose, prevent, mitigate, treat or cure the 2009 H1N1 influenza virus
Read the original:
FDA, FTC Warn Public of Fraudulent 2009 H1N1 Influenza Products
Prompted by reports of serious adverse events, the U.S.
Originally posted here:
FDA Requires Boxed Warning for All Botulinum Toxin Products
The Food and Drug Administration issued a final rule today that requires manufacturers of over-the-counter (OTC) pain relievers and fever reducers to revise their labeling to include warnings about potential safety risks, such as internal bleeding and liver damage, associated with the use of these popular drugs.
Here is the original post:
FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers to Help Consumers Use Products Safely
The U.S.
Read more:
SAMHSA and FDA Join to Educate the Public on the Safe Use of Methadone